Interferon-inducible Transmembrane Protein 3 (IFITM3) has an oncogenic role and promotes cell proliferation, cell migration through EMT, invasion stemness, bone metastasis, and PCa progression through activation of a novel TGF-β-Smads-MAPK pathway [52,53]. The gene discussed is TGFB1; the disease is posterior cortical atrophy.